A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors
ACS Nano · 25.07.2023 · 17 (14) · 13461-13473
DOI: 10.1021/acsnano.3c01743 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 14.07.2023. Verfasst von Ruirui Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Glutaminase, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Start-up Grant from Zhengzhou University, Postdoctoral Science Foundation of China.
Abstract (Originalsprache)
Competitive consumption of nutrients between rapidly proliferating cancer cells and T cells results in an immunosuppressive tumor microenvironment (TME) and nutrient deprivation of T cells, which can cause low response rate and resistance to immunotherapies. In this study, we proposed a dual-mechanism based nutrient partitioning nanoregulator (designated as DMNPN), which can simultaneously regulate the immunosuppressive TME and enhance T cell nutrient availability. DMNPN consists of a charge-reversal biodegradable mesoporous silica, encapsulating glycolysis inhibitor lonidamine, and small interfering RNA against glutaminase. Through inhibiting glycolysis to decrease the lactic acid production and downregulating glutaminase expression to reduce the uptake of glutamine by tumor cells, DMNPN enables effective remodeling of metabolism and nutrient partitioning, which alleviates the immunosuppressive TME and boosts nutrient availability for T cells with enhanced antitumor immunity. Such a nutrient partitioning nanoregulator can effectively inhibit the growth of anti-programmed death receptor 1 (anti-PD-1) resistant tumors and prevent tumor metastasis and recurrence. Overall, this dual-mechanism based nutrient reallocation strategy provides a promising approach for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
- Department of Ultrasound, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
ORCID-Profile: Xueqin Wang, Beibei Zhang
Förderung
- National Natural Science Foundation of China
- Start-up Grant from Zhengzhou University
- Postdoctoral Science Foundation of China
- Science and Technology Department of Henan Province
- Young Core Instructor Program in Higher Education Institution of Henan province
- Key Research and Development Projects in Henan Province
- Innovative Funds Plan of Henan University of Technology
Zitieren
APA
Zhang, R., Li, R., Zhang, L., Chen, G., Mo, L., Jiang, R., Xu, X., Wang, X., Zhao, Y., Zhang, L., Wang, Y., & Zhang, B. (2023). A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors. ACS Nano, 17(14), 13461-13473. https://doi.org/10.1021/acsnano.3c01743
Vancouver
Zhang R, Li R, Zhang L, Chen G, Mo L, Jiang R, et al. A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors. ACS Nano. 2023;17(14):13461-13473. doi:10.1021/acsnano.3c01743
BibTeX
@article{Zhang2023,
author = {Zhang, Ruirui and Li, Ruifang and Zhang, Lan and Chen, Ge and Mo, Lianfeng and Jiang, Ru and Xu, Xiaoxia and Wang, Xueqin and Zhao, Yingyuan and Zhang, Lianzhong and Wang, Yongchao and Zhang, Beibei},
title = {A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {14},
pages = {13461--13473},
doi = {10.1021/acsnano.3c01743}
}
EUVIMED